On Tuesday, October 5, Colin Hill will moderate a panel at the Longwood Healthcare Leaders meeting.

http://www.personalizedmedicineconference.org/schedule/ Precision Partnership: A Fireside Chat With Leaders From GNS Healthcare and the Multiple Myeloma Research Foundation  

This year’s 2020 STAT Health Tech Summit will engage industry leaders, from giants like Apple and Google to upstarts emerging from stealth to discuss how breakthroughs in health and medicine are not just biological – they are technological. The two-day event will...

Even with decades of research, treatment for many neurodegenerative diseases remain illusive. From Alzheimer's to Huntington’s, our collective understanding of these diseases has advanced, but only seen a trickle of clinical trial progress through the drug development...

Despite the unprecedented success of immune checkpoint inhibitors (ICI) in several cancer types, only a subset of patients derives clinical benefit. Companies leading the charge on ICI development are faced with many questions including: What are the molecular drivers...

Leveraging causal inference to understand patient response to treatment Finding AI solutions that accelerate pharmaceutical development and overcome challenges of more common predictive methods can be difficult. Join us for a webinar that demonstrates how...

Biopharma companies make big bets and investments in every single drug candidate that enters the drug development process. Yet, making difficult strategic decisions on which trials to pursue, how to design trials (e.g. head-to-head; which drug candidate;...

Selecting the right solution from the vast AI landscape & dive into the inner workings of applying causal AI to pharma R&D In this 30-minute webinar, the GNS Healthcare team introduces you to the complex landscape of AI and help you hone in on one specific...